Estimates Revisions Outlook Therapeutics, Inc.
Stocks
OTLK
US69012T3059
Biotechnology & Medical Research
|
Real-time Estimate
Cboe BZX
08:11:29 02/09/2026 pm IST
|
5-day change | 1st Jan Change | ||
| 0.6190 USD | -0.66% |
|
+0.87% | -60.21% |
| 28/08 | Outlook Therapeutics, Inc. Announces CFO Changes, Effective September 1, 2026 | CI |
| 28/08 | Outlook Therapeutics Appoints Kevin Lundquist as CFO | MT |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
EBIT - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| - | |||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
EBIT
- Stock Market
- Stocks
- OTLK Stock
- Consensus Outlook Therapeutics, Inc.
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
